False
November 6, 2026
Power List 2026 honoree Harold Keer traces oncology’s transformation – and considers what it will take to turn today’s “abundance of riches” into better patient outcomes
1 min read
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.
The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.
Barbara and Edward Netter Professor in Cancer Gene Therapy, University of Pennsylvania Perelman School of Medicine
View Profile
Claudia Zylberberg discusses building the infrastructure, partnerships, and policies needed to bring advanced therapies to patients at scale
All the latest Medicine Maker articles.
November 3, 2026
The company also reported early efficacy and safety data from the Phase I Breakfree-2 study
2 min read
November 3, 2026
China sets out its stall for global biopharmaceutical preeminence as the US faces further uncertainty over research funding and regulation
23 min read
November 3, 2026
Immunopeptidomics is helping researchers identify tumor-presented antigens that could inform the development of targeted cell therapies and personalized cancer vaccines
3 min read
November 2, 2026
Early characterization and manufacturing planning can help developers choose the right formulation strategy for complex oral therapies
5 min read
November 2, 2026
Review examines how PAT, model-based control, reinforcement learning, and digital twins could maintain product quality from perfusion culture through downstream purification
2 min read
November 2, 2026
Phase I data show B-cell depletion and mostly stable or improved disability scores, but the uncontrolled study remains small and follow-up is limited
2 min read
October 30, 2026
Erik Vaessen on the costs, complexities, and technologies shaping advanced therapy manufacturing.
5 min read
October 29, 2026
AmacaThera Co-Founder and CEO Mike Cooke reflects on the long road from academic discovery to a potential new treatment for post-operative pain
9 min read
October 28, 2026
Engineered T cells resisted tacrolimus but remained sensitive to cyclosporin, providing a potential way to select or suppress them after administration
2 min read
October 28, 2026
USC researchers develop a scalable cell engineering platform that could overcome key manufacturing and therapeutic limitations of CAR-based immunotherapies
2 min read
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.
False
